Ramosetron Hydrochloride is the hydrochloride salt of ramosetron, a selective serotonin (5-HT) receptor antagonist with potential antiemetic activity. Upon administration, ramosetron selectively binds to and blocks the activity of 5-HT subtype 3 (5-HT3) receptors located in the vagus nerve terminal and in the vomiting center in the central nervous system (CNS), suppressing chemotherapy-induced nausea and vomiting. It is grouped under the following drug class(es): Antiemetics. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Irribow and Nasea. Its PubChem CID is 107999.
Ramosetron hydrochloride
| CAS No | 132907-72-3 |
|---|---|
| Molecular Formula | C17H18ClN3O |
| Molecular Weight | 315.8 g/mol |
| Synonyms | (1-methylindol-3-yl)-[(5R)-4,5,6,7-tetrahydro-3H-benzimidazol-5-yl]methanone;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Ramosetron Hydrochloride is the hydrochloride salt of ramosetron, a selective serotonin (5-HT) receptor antagonist with potential antiemetic activity.
The listed CAS number is 132907-72-3.
The listed molecular formula is C17H18ClN3O.
The listed molecular weight is 315.8 g/mol.
(1-methylindol-3-yl)-[(5R)-4,5,6,7-tetrahydro-3H-benzimidazol-5-yl]methanone;hydrochloride.
The source lists Irribow and Nasea.